GTR Test Accession:
Help
Last updated in GTR:
View version history
GTR000530222.17, last updated: 2020-09-12
GTR000530222.16, last updated: 2020-09-09
GTR000530222.15, last updated: 2019-01-11
GTR000530222.14, last updated: 2018-10-10
GTR000530222.13, last updated: 2018-07-06
GTR000530222.12, last updated: 2018-06-21
GTR000530222.11, last updated: 2018-02-22
GTR000530222.10, last updated: 2018-02-21
GTR000530222.9, last updated: 2017-12-04
GTR000530222.8, last updated: 2017-08-31
GTR000530222.7, last updated: 2017-02-03
GTR000530222.6, last updated: 2017-01-11
GTR000530222.5, last updated: 2017-01-10
GTR000530222.4, last updated: 2017-01-03
GTR000530222.3, last updated: 2016-09-26
GTR000530222.2, last updated: 2016-07-08
GTR000530222.1, last updated: 2016-04-08
At a Glance
Conditions (47):
Help
Charcot-Marie-Tooth disease, type 2N; Age-related macular degeneration 3; Charcot-Marie-Tooth disease dominant intermediate 3; ...
Genes (38):
Help
AARS (16q22.1), AIFM1 (Xq26.1), COX6A1 (12q24.31), DHTKD1 (10p14), DNM2 (19p13.2), ...
Conditions
Help
Total conditions: 47
| Condition/Phenotype | Identifier |
|---|
Methodology
Total methods: 0
Method Category
Help
Test method
Help
Instrument *
* Instrument: Not provided
Technical Information
Recommended fields not provided:
Test Confirmation
Additional Information
Reviews:
Clinical resources:
Molecular resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.